Received 3 November 1994/Returned for modification 14 December 1994/Accepted 24 January 1995
|
|
- Cassandra McCoy
- 5 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL MICROBIOLOGY, May 1995, p Vol. 33, No /95/$ Copyright 1995, American Society for Microbiology DNA Fingerprinting and Phenotyping of Mycobacterium tuberculosis Isolates from Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Patients in Tanzania Z. H. YANG, 1 I. MTONI, 2 M. CHONDE, 2 M. MWASEKAGA, 2 K. FUURSTED, 1 D. S. ASKGÅRD, 1 J. BENNEDSEN, 1 P. E. W. DE HAAS, 3 D. VAN SOOLINGEN, 3 J. D. A. VAN EMBDEN, 3 AND Å. B. ANDERSEN 1 * Mycobacteria Department, Sector for Biotechnology, Statens Seruminstitut, Copenhagen, Denmark 1 ; Central TB Laboratory, National Institute for Medical Research, Dar es Salaam, Tanzania 2 ; and Unit of Molecular Microbiology and Laboratory of Bacteriology and Antimicrobial Agents, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands 3 Received 3 November 1994/Returned for modification 14 December 1994/Accepted 24 January 1995 With the purpose of determining whether the risk of infection with a particular clone of Mycobacterium tuberculosis is influenced by the human immunodeficiency virus (HIV) status of the host, we analyzed and compared 68 mycobacterial isolates obtained from HIV-seropositive with tuberculosis (TB) in Dar es Salaam, Tanzania, with 66 mycobacterial isolates obtained from HIV-seronegative with TB in the same geographical region by using both DNA fingerprinting and classical phenotyping methods. One hundred one different IS6110 fingerprinting patterns were observed in the 134 isolates. The level of diversity of the DNA fingerprints observed in the HIV-seropositive group was comparable to the level of the diversity observed in the HIV-seronegative group. Resistance to a single anti-tb drug was found in 8.8% of the tested isolates, and 3.2% of the isolates were resistant to more than one anti-tb drug. The drug susceptibility profiles were not significantly difference between the two groups of isolates compared in the present study. Phenotypic characteristics which classify M. tuberculosis strains as belonging to the Asian subgroup correlated with a low IS6110 copy number per isolate. However, the occurrence of Asian subgroup strains was not associated with the HIV status of the. The results of the study suggested an equal risk of infection with a defined M. tuberculosis clone for HIV-seropositive and HIV-seronegative individuals. * Corresponding author. Mailing address: Mycobacteria Department, Statens Seruminstitut, Artillerivej 5, DK-2300 Copenhagen S, Denmark. Phone: Fax: The emergence of the AIDS pandemic has caused profound changes in the epidemiological aspects of mycobacterial diseases both in developing and in industrialized countries (3 5, 15, 16, 21). A number of studies based on clinical observations (10, 12, 18 20, 27) and on epidemiological surveys (9, 17, 25) of tuberculosis (TB) and human immunodeficiency virus (HIV) seroprevalence have provided evidence that HIV infection is a risk factor for the development of active and often lethal TB. This might be explained by increased reactivation of previously acquired, dormant mycobacteria and enhanced susceptibility to both reinfection and primary infection. It was previously suggested (22) that reactivation is responsible for the major part of HIV-associated TB, especially in countries with a high level of TB transmission. However, study of the DNA fingerprints of Mycobacterium tuberculosis isolates obtained from AIDS by the technique of restriction fragment length polymorphism (RFLP) analysis showed that reinfection and new infection also occurs in AIDS (8, 14, 24). The development of DNA fingerprinting techniques for M. tuberculosis has permitted detailed studies of the transmission of TB. The method can effectively be used to distinguish between a newly acquired infection and a relapse (2, 5, 8, 11, 13, 14). It could be hypothesized that the HIV-infected population comprises an ecological niche for M. tuberculosis, also allowing less virulent strains to replicate freely without the selection pressure normally provided by an active cellular immune system. Despite a very efficient national TB control program, Tanzania has been suffering from high rates of TB for years and, since the early 1980s, from high rates of HIV infection as well. This is therefore a population in which it might be possible to clarify if this is indeed the case. We specifically analyzed mycobacterial strains isolated from HIV-seropositive individuals and compared them with strains isolated from HIVseronegative individuals in order to determine whether the risk of infection with a particular clone of M. tuberculosis is influenced by the HIV status of the host. The correlation of the relatedness among the strains examined was analyzed by both RFLP typing and classical phenotyping methods. The results of the study showed an equal risk of infection with a defined M. tuberculosis clone for HIV-seropositive and HIV-seronegative individuals. MATERIALS AND METHODS Bacterial isolates and clinical data. The isolates of M. tuberculosis were collected in Dar es Salaam by the Central TB Laboratory, National Institute for Medical Research of Tanzania, from admitted to the Muhimbili Medical Centre. The isolates were randomly sampled through a 7-month period from late 1992 to the beginning of Data on the concerning type of specimen, date of isolation, clinical diagnosis, TB status (pulmonary versus extrapulmonary), HIV status, chemotherapeutic regimens, and standard demographic data were registered. Of the 134 isolates, 68 were isolated from HIV-seropositive TB and 66 were obtained from HIV-seronegative TB. The mean ages for the two groups were 34.7 and 32.7 years, respectively (age ranges, from 18 to 61 years for the HIV-seropositive group and from 14 to 76 years for the HIV-seronegative group). All of the isolates were primary isolates. The species of mycobacteria were confirmed by a DNA-RNA hybridization technique (Gen-Probe Inc., San Diego, Calif.) and standard microbiological techniques. The susceptibilities of the isolates to ethambutol, isoniazid, streptomycin, rifampin, pyrazinamide, and fusidic acid were tested with the BACTEC system. The data concerning species identification and drug susceptibility were 1064
2 VOL. 33, 1995 MOLECULAR EPIDEMIOLOGY OF TB AND HIV STATUS 1065 obtained in parallel from both the laboratory in Tanzania and the laboratory at the Statens Seruminstitut in Copenhagen. The M. tuberculosis complex strains were, in addition, typed according to the criteria suggested by Collins and colleages (7) on the basis of their resistance to cycloserine and pyrazinamide, ability to grow on solid medium containing thiopheno-2-carboxylic acid hydrazide, oxygen preference, and ability to reduce nitrate in a standard in vitro assay. According to these analyses the isolates were divided into subgroups designated classical human, Asian human, African I, African II, and classical bovine. DNA fingerprinting. DNA fingerprinting was performed as described previously (28). In brief, the isolates were cultivated on Löwenstein-Jensen slopes at 37 C for 3 to 4 weeks. Chromosomal DNA was extracted from the bacteria with chloroform-isoamyl alcohol (24/1; vol/vol). The restriction endonuclease PvuII was used for digestion of the genomic DNA. Restriction fragments were separated by electrophoresis in a 0.8% agarose gel in 1 TBE (Tris-borate-EDTA) buffer overnight at 0.8 V/cm and were transferred onto a nylon membrane (Hybond N-plus; Amersham International plc, Buckinghamshire, United Kingdom) with a vacuum transfer device (Milliblot TM-v; Millipore Corp., Bedford, Mass.). The probe used in the study was a 245-bp PCR product of the right arm of IS6110 (29), which was purified by agarose electrophoresis and which was nonradioactively labelled with an enhanced chemiluminescence kit (Amersham International plc). Hybridization and detection were performed according to the instructions provided by the manufacturer of the enhanced chemiluminescence kit. The external marker for monitoring the separation of the restriction fragments during electrophoresis was a mixture of HindIII-digested bacteriophage lambda DNA and HaeIII-digested X174 DNA. The internal marker included to facilitate the computer-assisted determination of the size of each IS6110-hybridizing fragment for comparison of DNA fingerprints was a mixture of PvuIIdigested supercoiled DNA ladder and HaeIII-digested X174 DNA. The reference DNA included in all experiments as a control was the chromosomal DNA extracted from M. tuberculosis Mt (Strain Collection, Laboratory of Bacteriology and Antimicrobial Agents, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands). Analysis of RFLP patterns. The DNA fingerprint patterns of the mycobacterial isolates were analyzed and compared by a computer-assisted analysis as described previously (30). The software used for the analysis was Bioimage Whole Band Analyzer, version 3 (Millipore Corporation, Ann Arbor, Mich.). RESULTS Phenotypic characteristics of the strains. A total of 134 isolates obtained from with newly diagnosed cases of TB at a major referral center in Dar es Salaam were included in the present study. Of these 134 isolates, 1 was identified as Mycobacterium bovis and the rest were all confirmed to be M. tuberculosis. One hundred twenty-five isolates were tested for their susceptibilities to conventional anti-tb drugs like ethambutol, isoniazid, streptomycin, rifampin, and pyrazinamide. The isolates were, in addition, tested for their susceptibilities to fusidic acid, which is known to be potent against other gram-positive bacteria. The resistance profiles of the isolates are given in Table 1. Eleven isolates (8.8%) were observed to be resistant to only a single drug. Four isolates (3.2%) were found to be resistant to two or more of the drugs. No relationship between HIV status and anti-tb drug susceptibilities was observed. Apart from phage typing, one of the previously described methods available for subtyping strains belonging to the TB complex is based on phenotypic markers like oxygen preference and the ability of the strains to reduce nitrate in an in vitro assay. These results were combined with susceptibility to pyrazinamide and cycloserine and the ability to grow in the presence of thiopheno-2-carboxylic acid hydrazide, whereby the isolates were assigned to subgroups, as summarized in Table 2. The occurrence of each of the variants was not associated with the HIV status of the TB patient. RFLP patterns. The RFLP patterns of the 134 isolates investigated are given in Fig. 1 by two-lane maps (HIV seropositive versus HIV seronegative). One hundred five different IS6110 fingerprinting patterns were observed in the 134 isolates, and 45 of the isolates showed RFLP patterns identical to from one to six isolates. The IS6110 copy number of the isolates ranged from 1 to 20. Thirty-five isolates (26.1%) carried TABLE 1. Drug resistance profiles of M. tuberculosis isolates from Dar es Salaam in relation to HIV status of the a Group b Drug No. (%) of resistant isolates from: HIV-seropositive HIV-seronegative Total I Isoniazid (2.4) Streptomycin (2.4) Pyrazinamide (1.6) Fusidic acid (2.4) II Isoniazid (1.6) Rifampin Streptomycin Isoniazid (0.8) Streptomycin Isoniazid (0.8) Pyrazinamide Total (12.0) a A total of 125 isolates were tested. b Group I includes isolates resistant to one drug, and group II includes isolates resistant to two or more drugs. one to five copies of the IS6110 element. The isolates carrying only a single copy of the IS6110 element accounted for about 8% of the total number investigated. A clear correlation between the occurrence of a low number of IS6110 elements per chromosome and classification into the Asian subgroup was observed. A total of 16 isolates were classified as belonging to the Asian subgroup. Fourteen of these isolates carried from one to five IS6110 copies, and two carried seven or eight IS6110 copies. The Asian subgroup made up 40% of the total number of isolates carrying only a low IS6110 copy number (n 35). The single IS6110 copy was, as shown in Fig. 1, integrated into two different chromosomal locations. One of the sites was the so-called hot spot for integration of IS6110 located on a 1.5-kb PvuII restriction fragment, and the other site was on a 5-kb PvuII restriction fragment. Despite the great diversity of the patterns among the isolates, a computer-assisted similarity analysis demonstrated a relatively high level of relatedness among a large number of different patterns. About 45% of the patterns were included in three big clusters. The similarity among the individual nonidentical patterns within each of the three clusters ranged from 70 to 96 percent (Fig. 2). This relatively high level of similarity is also demonstrated by the lane map. TABLE 2. Variants of M. tuberculosis complex strains from Dar es Salaam Subgroup HIV-seropositive No. (%) of isolates from: HIV-seronegative Total Classical human (87.3) Asian human (11.9) Classical bovine (0.8) African I (0) African II (0) Total (100)
3 FIG. 1. Computer-generated lane maps displaying all of the DNA fingerprints of the analyzed isolates. (A) Lane map showing the 68 isolates obtained from HIV-seropositive. (B) Lane map showing the 66 isolates obtained from HIV-seronegative except for the first lane, which holds the same isolate as that in lane 1 in the lane map in panel A. Use of the same isolate as a matching reference in generating the lane maps facilitates comparison of the two sets of data. The sizes of the standard DNA fragments (in kilobase pairs) are indicated on the left. 1066
4 VOL. 33, 1995 MOLECULAR EPIDEMIOLOGY OF TB AND HIV STATUS 1067 FIG. 2. Dendrogram based on computer-assisted comparison of IS6110 DNA fingerprints of 134 isolates of M. tuberculosis. The numbers of isolate and the HIV status of the related to these isolates are indicated at the right side of the dendrogram:, HIV seropositive;, HIV seronegative. The similarity among the patterns is indicated below the dendrogram as a percentage. Fifteen patterns were shared by two or more isolates. No correlation was found between drug susceptibility and the RFLP patterns of the isolates. Geographical distribution of the M. tuberculosis clones. Geographically, the city of Dar es Salaam is divided into three districts: Kinondoni, Ilala, and Temeke. These three districts cover approximately 1,800 km 2. A clear correlation between the geographical origin and the genetically defined clusters of the isolates was observed. It appeared that certain clusters of strains were predominant in particular regions or in two neighboring districts (data not shown). Comparison of the RFLP patterns between HIV-seropositive and HIV-seronegative TB. The level of the diversity of the DNA fingerprints observed in the HIV-seropositive TB group was comparable to the level of diversity observed in the HIV-seronegative TB group. As exemplified in Fig. 1, 60 DNA fingerprint patterns were observed among 68 isolates obtained from HIV-seropositive TB, and 56 patterns were found among 66 isolates derived from HIV-seronegative TB. The risk of belonging to a group of with identical RFLP patterns (to be understood as the risk of belonging to a chain of recent TB transmission) was 36.8% for the HIV-seropositive group and 30.3% for the HIV-seronegative group (P 0.10). When these patterns were assigned to the predominant clusters, the isolates segregated randomly and were not associated with the HIV status of the. This was also reflected in the number of IS6110 copies per isolate, which ranged from 1 to 18 for the HIV-seropositive group and from 1 to 20 for the HIV-seronegative group. As demonstrated in Fig. 3, the frequency of occurrence of IS6110 in the investigated isolates appeared to be rather similar between the two groups being compared. The three relatively prevalent patterns observed in the study, which each contained five or seven isolates, included isolates obtained from both HIV-seropositive and HIV-seronegative. DISCUSSION The pathogenesis of HIV-associated TB is as yet far from clear. The sequence of events may be either a primary or a secondary exogenous infection of a highly susceptible HIVinfected host or reactivation of previously acquired dormant bacteria. However, it is obvious that infected by both HIV and M. tuberculosis have an accelerated progression to overt tuberculous disease. Tanzania is one of the countries in Africa in which a very extensive anti-tb campaign has been implemented. A national tuberculosis program was initiated in 1978 in which short-course anti-tb therapy was introduced in all regions of the country. Initially, this led to a significant decrease in the number of new cases of TB up to Despite these efforts, since 1983, when the first case of AIDS was officially reported in Tanzania, this positive trend was reversed into a tragic increase in the incidence of TB, especially during the last 2 or 3 years. The HIV seroprevalence in 1992 was reported to be as high as 7% for adult female blood donors and 5.4% for adult male blood donors (16a). The purpose of the present study was to study the influence of the HIV status of the host on the mycobacterial infection. In particular, we wanted to assess whether certain mycobacterial strains characterized by either RFLP pattern or any phenotypic characteristics could be identified. The correlation between these two methods, genotyping (IS6110 RFLP pattern) and phenotyping, was also examined. By use of IS6110 DNA fingerprinting the degree of DNA polymorphism of M. tuberculosis strains isolated in Dar es Salaam was found to be similar to that recently observed in New York and San Francisco (1, 23) because the average number of isolates per pattern was 1.33 for the present study, whereas for the study in New York it was 1.35 and for the study in San Francisco it was 1.5. It might be expected that regions suffering from a high level of TB transmission and insufficient
5 1068 YANG ET AL. J. CLIN. MICROBIOL. FIG. 3. Number of IS6110 copies per strain. Closed bars, strains isolated from HIV-seropositive ; open bars, strains isolated from HIV-seronegative. hospital facilities with a high risk of nosocomial infections would be characterized by a relatively limited variety of mycobacterial clones. The diversity of the patterns observed in the present study may be explained by the fact that Dar es Salaam is a large city inhabited by people originating from many parts of Tanzania as well as a large number of immigrants, especially from Asia but also from the Arab world. Furthermore, Dar es Salaam is one of the major trade centers of eastern Africa. In contrast to recent observations from a large-scale RFLP study of M. tuberculosis isolates in Tunisia (6) and an ongoing study in Denmark (31), the number of IS6110 copies observed in the isolates investigated in the present study was rather evenly distributed within a range of from 1 to 20. In the study in Tunisia, about 75% of the investigated isolates of M. tuberculosis were found to carry from 6 to 10 copies of the IS6110 element. In the study in Denmark, about half of the isolates analyzed carried from 11 to 15 copies of the insertion element. The proportion of isolates with a low copy number or only one copy of the IS6110 element was much larger in the present study (26.1%) than in any of the two studies mentioned above (8.6% in the Danish study and 5.5% in the Tunisian study). Despite the observation of a large number of unique patterns, more than 40% of the patterns could be assigned to three big clusters, each of which revealed a high degree of genetic similarity among the isolates. This observation is in accordance with the fact that TB has haunted this part of the world for generations. Although the stability of the IS6110 element is high, it is by nature transposable, and the highly related but nonidentical patterns reflect the result of evolution through generations of TB infection in this region. Although the diversity of the patterns, as mentioned above, was great, the relatedness of the DNA fingerprint patterns tended to be in accordance with the geographical origins of the isolates, as also reported previously by others (14, 30). By comparing the RFLP patterns of HIV-related M. tuberculosis isolates with the RFLP patterns of non-hiv-related isolates, we found that the DNA fingerprints were equally polymorphic in the two groups. The patterns shared by two or more isolates were, in most cases, observed in both HIVrelated TB and non-hiv-related TB groups. It might be expected that HIV-related TB could be associated with special clones of mycobacteria with low levels of virulence which would be able to infect the immunocompromised host. However, from the present study we found no indication that any particular clones of M. tuberculosis have played any dominant role in the HIV-related TB. This was also reflected in the observation that infection with strains of M. tuberculosis of the Asian subgroup, which mainly contained a low number of IS6110 copies, was not associated with the HIV status of the patient. In industrialized countries HIVassociated TB is characterized by a higher incidence of extrapulmonary TB, and therefore probably has fewer infectious manifestations. However, in a country with a high level of TB transmission like Tanzania, more than 50% of the HIV-positive have pulmonary TB, as in the present study, in which all of the HIV-positive had pulmonary, smearpositive TB. Resistance to anti-tb drugs can develop during the initial infection, but it may also occur as a result of reinfection with drug-resistant strains of M. tuberculosis. Exogenous reinfection with multidrug-resistant M. tuberculosis may happen either during therapy of the original infection or after therapy has been completed (24). In the present study, drug resistance to one or more anti-tb drugs was found in 12% of the tested isolates. The isolates resistant to more than one anti-tb drug accounted for 3.2% of the total number of isolates tested. Since all of the isolates were primary isolates, the drug resistance found in the present study should be considered primary drug resistance. The drug susceptibility profiles obtained from the present study showed that there was no significant difference between the two groups of isolates being compared. The low rate of primary drug resistance observed in the present
6 VOL. 33, 1995 MOLECULAR EPIDEMIOLOGY OF TB AND HIV STATUS 1069 study showed that, despite the substantial difficulties in Tanzania, as in all other developing countries, the national TB control program in Tanzania has proved to be quite efficient. In accordance with previous findings (6, 26), there was no correlation between DNA fingerprint patterns and drug resistance. However, phenotypic characteristics which classify M. tuberculosis strains as being of the Asian subgroup correlated with a low IS6110 copy number per isolate. The relationship between the IS6110-associated RFLP and other phenotypic characteristics like the virulence of the bacteria, with all of the inherent problems of defining and assaying this trait, remains to be studied further. The data presented in this paper have been entered into the centralized, international database which is being established at the National Institute of Public Health and Environmental Protection (Rijksinstitut voor Volkgezondheid en Milieuhygiëne) in Bilthoven, The Netherlands, and may thereby contribute to future studies on the molecular epidemiology of TB. ACKNOWLEDGMENTS We thank all of the members of the staff at the Central TB Laboratory at the National Institute for Medical Research of Tanzania, at the Laboratory of Bacteriology and Antimicrobial Agents at the National Institute of Public Health and Environmental Protection of The Netherlands, and at the Mycobacteria Department at the Statens Seruminstitut in Denmark for support and assistance during the study. The interest and support of Viggo Faber and I. Bygbjerg at the Department of Infectious Medicine at the University Hospital, Rigshospitalet, Copenhagen, is gratefully acknowledged. This study was supported by a grant from the Commision of the European Communities, DG XII, Biomedical and Health Research, STD3 programme (contract TS3*-CT ), and Biomed 1 (contract BMH1-CT ). REFERENCES 1. Alland, D., G. E. Kalkut, A. R. Moss, R. A. McAdam, J. A. Hahn, W. Bosworth, E. Drucker, and B. R. Bloom Transmission of tuberculosis in New York city, an analysis by DNA fingerprinting and conventional epidemiologic methods. N. Engl. J. Med. 330: Beck-Sagué, C., S. W. Dooley, M. D. Hutton, J. Otten, A. Breeden, J. T. Crawford, A. E. Pitchenik, C. Woodley, G. Cauthen, and W. R. Jarvis Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. JAMA 268: Brudney, K., and J. Dobkin Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am. Rev. Respir. Dis. 144: Centers for Disease Control Nosocomial transmission of multidrugresistant tuberculosis among HIV infected persons Florida and New York, Morbid. Mortal. Weekly Rep. 40: Centers for Disease Control Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system New York, Morbid. Mortal. Weekly Rep. 41: Chevrel-Dellagi, D., A. Abderrahman, R. Haltiti, H. Koubaji, B. Gicquel, and K. Dellagi Large-scale DNA fingerprinting of Mycobacterium tuberculosis as a tool for epidemiological studies of tuberculosis. J. Clin. Microbiol. 31: Collins, C. H., M. D. Yates, and J. M. Grange Subdivision of Mycobacterium tuberculosis into five variants for epidemilogical purposes: methods and nomenclature. J. Hyg. 89: Daley, C. L., P. M. Small, G. F. Schecter, G. K. Schoolnik, R. A. McAdam, W. R. Jacobs, Jr., and P. C. Hopewell An outbreak of tuberculosis with the human immunodeficiency virus: an analysis using restriction fragment length polymorphisms. N. Engl. J. Med. 326: De Cock, K. M., B. Soro, I. M. Coulibaly, and S. B. Lucas Tuberculosis and HIV infection in sub-saharan Africa. JAMA 268: Dooley, S. W., M. E. Villarrino, M. Lawrence, L. Salinas, S. Amil, J. V. Rullan, W. R. Jarvis, A. B. Bloch, and G. M. Cauthen Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected. JAMA 267: Edlin, B. R., J. I. Tokars, M. H. Grieco, J. T. Crawford, J. Williams, E. M. Sordillo, K. R. Ong, J. O. Kilburn, S. W. Dooley, K. G. Castro, W. R. Jarvis, and S. D. Holmberg An outbreak of multidrug-resistant tuberulosis among hospitalized with the acquired immunodeficiency syndrome. N. Engl. J. Med. 326: Fischl, M. A., R. B. Uttamchandani, G. L. Daikos, R. B. Poblete, J. N. Moreno, R. R. Reyes, A. M. Boota, L. M. Thompson, T. J. Cleary, and S. Lai An outbreak of tuberculosis caused by multiple-drug resistant tubercle bacilli among with HIV infection. Ann. Intern. Med. 117: Godfrey-Faussett, P., P. R. Mortimer, P. A. Jenkins, and N. G. Stoker Evidence of transmission of tuberculosis by DNA fingerprinting. Br. Med. J. 305: Godfrey-Faussett, P., and N. G. Stoker Aspects of tuberculosis in Africa. 3. Genetic fingerprinting for clues to the pathogenesis of tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 86: Harries, A. D Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 335: Hopewell, P. C Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin. Infect. Dis. 15: a.National AIDS Control Programme Surveillance report no. 7. National AIDS Control Program, Dar es Salaam, Tanzania. 17. Onorato, I. M., E. McCray, and the Field Services Branch Prevalence of human immunodeficiency virus infection among attending tuberculosis clinics in the United States. J. Infect. Dis. 165: Pape, J. W., B. Liautaud, F. Thomas, J. R. Mathurin, M. M. A. S. Amand, M. Boncy, V. Pean, M. Pamphile, A. C. Laroche, and W. D. Johnson Characteristics of the acquired immunodeficiency syndrom (AIDS) in Haiti. N. Engl. J. Med. 309: Piot, P., T. C. Quinn, H. Taelman, F. M. Feinsod, K. B. Minlangu, O. Wobin, N. Mbendi, P. Mazebo, K. Ndangi, W. Stevens, K. Kalambayi, S. Mitchell, C. Bridts, and J. B. McCormick Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet ii: Pitchenikn, A. E., M. A. Fischl, G. M. Dickinson, D. M. Becker, A. M. Fournier, M. T. O Connell, R. M. Colton, and T. J. Spira Opportunistic infections and Kaposi s sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann. Intern. Med. 98: Raviglione, M. C., P. Sudre, H. L. Rieder, S. Spinaci, and A. Kochi Secular trends of tuberculosis in Western Europe. Bull. W. H. O. 71: Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoeubaum, S. H. Vermundet, R. S. Klein, A. T. Walker, and G. H. Friedland A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320: Small, P. M., P. C. Hopewell, S. P. Singh, A. Paz, J. Parsonnet, D. C. Ruston, G. F. Schecter, C. L. Daley, and G. K. Schoolnik The epidemiology of tuberculosis in San Francisco, a population-based study using conventional and molecular methods. N. Engl. J. Med. 30: Small, P. M., R. W. Shafer, P. C. Hopewell, S. P. Singh, M. J. Murphy, E. Desmond, M. F. Sierra, and G. K. Schoolnik Exogenous reinfection with multidrug-resistant M. tuberculosis in with advanced HIV infection. N. Engl. J. Med. 328: Sudre, P., G. T. Dam, and A. Kochi Tuberculosis: a global overview of the situation today. Bull. W. H. O. 70: Thierry, D., P. Matsiota-Bernard, E. Pitsouni, C. Costopoulos, and J.-L. Guesdon Use of the insertion element IS6110 for DNA fingerprinting of Mycobacterium tuberculosis isolates presenting various profiles of drug susceptibility. FEMS Immunol. Med. Microbiol. 6: Van de Perre, P., D. Rouvroy, P. Lepage, J. Bogaerts, P. Kestelyn, J. Kayihigi, A. C. Hekker, and J. P. Butzier Acquired immunodeficiency syndrom in Rwanda. Lancet ii: Van Embden, J. D. A., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. W. M. Hermans, C. Martin, R. Mcadam, T. M. Shinick, and P. M. Small Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendation for a standardized methodology. J. Clin. Microbiol. 31: Van Soolingen, D., P. E. W. de Haas, P. W. M. Hermans, P. M. A. Groenen, and J. D. A. van Embden Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J. Clin. Microbiol. 29: Yang, Z. H., P. E. W. de Haas, D. van Soolingen, J. D. A. van Embden, and Å. B. Andersen Restriction fragment length polymorphism of Mycobacterium tuberculosis strains isolated from Greenland during Evidence of tuberculosis transmission between Greenland and Denmark. J. Clin. Microbiol. 32: Yang, Z. H., P. E. W. de Haas, C. H. Wachmann, D. van Soolingen, J. D. A. van Embden, and Å. B. Andersen Unpublished data.
Usefulness of Spoligotyping To Discriminate IS6110 Low-Copy- Number Mycobacterium tuberculosis Complex Strains Cultured in Denmark
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1999, p. 2602 2606 Vol. 37, No. 8 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Usefulness of Spoligotyping To Discriminate
More informationMolecular Epidemiology of Mycobacterium tuberculosis Strains Isolated during a 3-Year Period (1993 to 1995) in Seville, Spain
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1997, p. 2472 2476 Vol. 35, No. 10 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Molecular Epidemiology of Mycobacterium tuberculosis Strains
More informationStability of Mycobacterium tuberculosis DNA Genotypes
1107 7. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug- 11. Dwyer B, Jackson K, Raios K, Sievers A, Wilshire E, Ross B. DNA resistant tuberculosis in the United States. JAMA 1994;271:665
More informationThe New England Journal of Medicine EXOGENOUS REINFECTION AS A CAUSE OF RECURRENT TUBERCULOSIS AFTER CURATIVE TREATMENT
EXOGENOUS REINFECTION AS A CAUSE OF RECURRENT TUBERCULOSIS AFTER CURATIVE TREATMENT ANNELIES VAN RIE, M.D., ROBIN WARREN, PH.D., MADELEINE RICHARDSON, M.SC., THOMAS C. VICTOR, PH.D., ROBERT P. GIE, M.D.,
More informationSimultaneous Detection and Strain Differentiation of Mycobacterium tuberculosis for Diagnosis and Epidemiology
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1997, p. 907 914 Vol. 35, No. 4 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Simultaneous Detection and Strain Differentiation of Mycobacterium
More informationAugust 30, 1991 / 40(34);
August 30, 1991 / 40(34);585-591 Epidemiologic Notes and Reports Nosocomial Transmission of Multidrug-Resistant Tuberculosis Among HIV-Infected Persons -- Florida and New York, 1988-1991 During 1990 and
More informationPATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA
PATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA DN Magana-Arachchi 1, AJ Perera 1, V Senaratne 2 and NV Chandrasekharan
More informationRepetitive DNA as a Tooi to Study the Genetic Variation and Epidemiology of Mycobacterium tuberculosis
Jan D.A. van Embden', Petra de Haas 2, Herre Heersma', Leo Schouls', Jim Douglas 3, Lishi Qiang 3, Peter W.M. Hermans 4, Feriele Messadi 5, Francoise Portaels 6 and Dick van Soolingen 2 Repetitive DNA
More informationMolecular Epidemiology of Mycobacterium tuberculosis Isolated from Pulmonary Patients in Iraq
Biological and Applied Environmental Research, 2017 Volume 1, Number 1, 57-68 Molecular Epidemiology of Mycobacterium tuberculosis Isolated from Pulmonary Patients in Iraq IBRAHEEM AL-JEBORY 1 *, ALI AL-ZAAG
More informationMolecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis
Molecular Epidemiology of Tuberculosis Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Overview TB transmission and pathogenesis Genotyping methods Genotyping for clinical management
More informationLeonard V. Sacks, Stella Pendle, Dragana Orlovic, Lucille Blumberg, and Constantinos Constantinou
96 A Comparison of Outbreak- and Nonoutbreak-Related Multidrug-Resistant Tuberculosis Among Human Immunodeficiency Virus Infected Patients in a South African Hospital Leonard V. Sacks, Stella Pendle, Dragana
More informationTHE emergence of multidrug-resistant tuberculosis
Vol. 333 No. 14 MULTIDRUG-RESISTANT TUBERCULOSIS IN PATIENTS WITHOUT HIV INFECTION 907 MULTIDRUG-RESISTANT TUBERCULOSIS IN PATIENTS WITHOUT HIV INFECTION EDWARD E. TELZAK, M.D., KENT SEPKOWITZ, M.D., PETER
More informationGlobal Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics
Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948
More informationThe authors assessed drug susceptibility patterns
Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division
More informationThe epidemiology of infectious diseases has traditionally relied on observed
Genetic fingerprinting in the study of tuberculosis transmission Sophie Kulaga, MSc; Marcel A. Behr, MD, MSc; Kevin Schwartzman, MD, MPH The epidemiology of infectious diseases has traditionally relied
More informationDifferentiation of Mycobacterium bovis Isolates from Animals by DNA Typing
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1996, p. 2469 2474 Vol. 34, No. 10 0095-1137/96/$04.00 0 Copyright 1996, American Society for Microbiology Differentiation of Mycobacterium bovis Isolates from Animals
More informationT he decline in tuberculosis (TB) in industrialised countries
618 TUBERCULOSIS Epidemiology of tuberculosis on Gran Canaria: a 4 year population study using traditional and molecular approaches M J Pena, J A Caminero, M I Campos-Herrero, J C Rodríguez-Gallego, M
More informationTransmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis
Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis Sofía Samper, Carlos Martín, Alfonso Pinedo*, Antonio Rivero, Jesús Blázquez, Fernando Baquero,
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationUse of Genetic Distance as a Measure of Ongoing Transmission of Mycobacterium tuberculosis
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2003, p. 5640 5644 Vol. 41, No. 12 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.12.5640 5644.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationOccasional review. typing of Mycobacterium tuberculosis. Restriction fragment length polymorphism. drugs.' Bacteriophage typing is hampered by
Thorax 1995;50:1211-1218 1211 Occasional review PHLS Communicable Disease Surveillance Centre, London NW9 SEQ, UK A C Hayward Received 20 February 1995 Returned to authors 5 June 1995 Revised version received
More information/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved.
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2001, p. 1042 1047 Vol. 39, No. 3 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.3.1042 1047.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationTuberculosis Disparity Between US-born African-Americans and Caucasians in Houston:
Tuberculosis Disparity Between US-born African-Americans and Caucasians in Houston: A population-based study Jose A. Serpa 1, M.D.; Larry D. Teeter 2, Ph.D., James M. Musser 2, M.D., Ph.D. and Edward A.
More informationRisk factors for tuberculosis among HIV-infected patients in Switzerland
Eur Respir J, 1996, 9, 279 283 DOI: 10.1183/09031936.96.09020279 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Risk factors for tuberculosis
More informationTuberculosis in Greenland current situation and future challenges
Tuberculosis in Greenland current situation and future challenges Thomsen VØ 1, Lillebaek T 1, Stenz F 2,*. 1 International Reference Laboratory of Mycobacteriology, Statens Serum Institut (SSI), the National
More informationMycobacterium bovis Strains from Animals and Humans and for
JOURNAL OF CLNCAL MCROBOLOGY, OCt. 1994, p. 24252433 951137/94/$4.+ Vol. 32, No. 1 Use of Various Genetic Markers in Differentiation of Mycobacterium bovis Strains from Animals and Humans and for Studying
More informationTransmission of tuberculosis in the metropolitan area of Zurich: a 3 year survey based on DNA fingerprinting
Eur Respir J 1998; 11: 804 808 DOI: 10.1183/09031936.98.11040804 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1998 European Respiratory Journal ISSN 0903-1936 Transmission of tuberculosis
More informationRisk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia
Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia Abdulrahman A. Alrajhi, MD, MPH, Shahab Abdulwahab, MRCP, Edna Almodovar, RMT, Hail M. Al-Abdely, MD. ABSTRACT Objective: To identify
More informationRisk Factors for Rifampin-monoresistant Tuberculosis A Case-Control Study
Risk Factors for Rifampin-monoresistant Tuberculosis A Case-Control Study LAURIE SANDMAN, NEIL W. SCHLUGER, AMY L. DAVIDOW, and STANLEY BONK Division of Pulmonary and Critical Care Medicine, Department
More informationMolecular Epidemiology of Extrapulmonary Tuberculosis
Molecular Epidemiology of Extrapulmonary Tuberculosis A Maryland State Review Jessie Torgersen PHASE Intern Maryland State Department of Health and Mental Hygiene Division of TB Control May 12, 2004 Outline
More informationHigh Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India
BRIEF REPORT High Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India Deepak Almeida, 1 Camilla Rodrigues, 2 Tester
More informationTransmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos
Transmissibility, virulence and fitness of resistant strains of M. tuberculosis CHIANG Chen-Yuan MD, MPH, DrPhilos Transmissibility, Virulence and Fitness of resistant strains of M. tuberculosis For infectious
More informationDiversity of Mycobacterium tuberculosis Isolates in an Immigrant Population: Evidence against a Founder Effect
American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 159, No. 5 Printed in U.S.A. DOI: 10.1093/aje/kwh065 Diversity of Mycobacterium
More informationRisk of Mycobacterium tuberculosis Transmission in a Low-Incidence Country Due to Immigration from High-Incidence Areas
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2001, p. 855 861 Vol. 39, No. 3 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.3.855 861.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Risk
More informationCharacteristics of Mycobacterium
Mycobacterium Characteristics of Mycobacterium Very thin, rod shape. Culture: Aerobic, need high levels of oxygen to grow. Very slow in grow compared to other bacteria (colonies may be visible in up to
More informationto the Public Health Laboratory Service (PHLS) for
Journal of Epidemiology and Community Health, 1986, 40, 295-300 The nature of mycobacterial disease in south east England, 1977-84 MALCOLM D YATES, JOHN M GRANGE, AND CHRISTOPHER H COLLINS From the Public
More informationDiagnosis of drug resistant TB
Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million
More informationDNA FINGERPRINTING. Barry N. Kreiswirth, PhD Director, PHRI TB Center
DNA FINGERPRINTING Barry N. Kreiswirth, PhD Director, PHRI TB Center Molecular Epidemiology Local Epidemiology Are M. tuberculosis isolates recovered from localized cases of disease the same or different
More informationTB Laboratory for Nurses
TB Laboratory for Nurses Shea Rabley, RN, MN Consultant Mayo Clinic Center for Tuberculosis 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Participants will be able to: 1. Name 2 safety
More informationAkujobi CN, Okoro CE, Anyabolu AE, Okonkwo RC, Onwunzo MC and Chukwuka CP
Akujobi CN, Okoro CE, Anyabolu AE, Okonkwo RC, Onwunzo MC and Chukwuka CP Tuberculosis (TB) is the most common opportunistic infection in Human Immunodeficiency Virus (HIV)-infected patients. 1 HIV-infected
More informationRapid detection of multidrug-resistant tuberculosis
Eur Respir J 1997; 10: 1120 1124 DOI: 10.1183/09031936.97.10051120 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 Rapid detection of multidrug-resistant
More informationReceived 11 June 2004/Returned for modification 13 August 2004/Accepted 15 September 2004
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2005, p. 89 94 Vol. 43, No. 1 0095-1137/05/$08.00 0 doi:10.1128/jcm.43.1.89 94.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Sensitivities
More informationTRADITIONALLY, ACTIVE TUBERculosis
ORIGINAL CONTRIBUTION Clinical and Radiographic Correlates of Primary and Reactivation Tuberculosis A Molecular Epidemiology Study Elvin Geng, MD, MPH Barry Kreiswirth, PhD Joe Burzynski, MD, MPH Neil
More informationTransmission Classification Model To Determine Place and Time of Infection of Tuberculosis Cases in an Urban Area
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2008, p. 3924 3930 Vol. 46, No. 12 0095-1137/08/$08.00 0 doi:10.1128/jcm.00793-08 Copyright 2008, American Society for Microbiology. All Rights Reserved. Transmission
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationProgress towards tuberculosis elimination: secular trend, immigration and transmission
Eur Respir J 2010; 36: 339 347 DOI: 10.1183/09031936.00155409 CopyrightßERS 2010 Progress towards tuberculosis elimination: secular trend, immigration and transmission M.W. Borgdorff*,#, S. van den Hof
More informationProgress towards tuberculosis elimination: secular trend, immigration and. transmission
ERJ Express. Published on December 8, 2009 as doi: 10.1183/09031936.00155409 Progress towards tuberculosis elimination: secular trend, immigration and transmission Martien W. Borgdorff [1,2], Susan van
More informationF. A. Drobniewski,* A. Gibson, M. Ruddy, and M. D. Yates
JOURNAL OF CLINICAL MICROBIOLOGY, May 2003, p. 1861 1868 Vol. 41, No. 5 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.5.1861 1868.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationReceived 24 January 2006/Returned for modification 29 April 2006/Accepted 14 June 2006
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2006, p. 2890 2896 Vol. 44, No. 8 0095-1137/06/$08.00 0 doi:10.1128/jcm.00160-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Strain-Specific
More informationCMH Working Paper Series
CMH Working Paper Series Paper No. WG5 : 8 Title Interventions to reduce tuberculosis mortality and transmission in low and middle-income countries: effectiveness, cost-effectiveness, and constraints to
More informationFactors Influencing Time to Sputum Conversion Among Patients with Smear-Positive Pulmonary Tuberculosis
666 Factors Influencing Time to Sputum Conversion Among Patients with Smear-Positive Pulmonary Tuberculosis Edward E. Telzak, Barkat A. Fazal, Cathy L. Pollard, Glenn S. Turett, Jessica E. Justman, and
More informationThe impact of drug resistance on the global tuberculosis epidemic
INT J TUBERC LUNG DIS 4(2):S71 S75 2000 IUATLD The impact of drug resistance on the global tuberculosis epidemic N. W. Schluger The Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia
More informationTuberculosis in Chicago 2006
Chicago Department of Public Health May 27 Communicable Disease Information Tuberculosis in Chicago 26 City of Chicago Richard M. Daley, Mayor Department of Public Health Terry Mason, MD, FACS Commissioner
More informationExtensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa Neel R Gandhi, Anthony Moll, A Willem Sturm, Robert Pawinski,
More informationStrain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients
International Journal of Infectious Diseases (2009) 13, 236 242 http://intl.elsevierhealth.com/journals/ijid Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary
More informationResponse to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria.
Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria. Yusuf Mohammed, Mukhtar Dauda, Ifeanyi Oyeyi TB/HIV Unit, International
More informationTuberculosis Transmission by Patients with Smear- Negative Pulmonary Tuberculosis in a Large Cohort in The Netherlands
MAJOR ARTICLE Tuberculosis Transmission by Patients with Smear- Negative Pulmonary Tuberculosis in a Large Cohort in The Netherlands Alma Tostmann, 1,2 Sandra V. Kik, 3,4 Nico A. Kalisvaart, 3 Maruschka
More informationClinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis
Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Amit S. Chitnis, MD, MPH; Pennan M. Barry, MD, MPH; Jennifer M. Flood, MD, MPH. California Tuberculosis Controllers
More informationMolecular Characterization of Mycobacterium tuberculosis H37Rv/Ra Variants: Distinguishing the Mycobacterial Laboratory Strain
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2000, p. 3200 3204 Vol. 38, No. 9 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Molecular Characterization of Mycobacterium
More informationTuberculosis. Impact of TB. Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH)
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 20 Tuberculosis Learning Objectives 1. Describe the biologic characteristics of the agent 2. Determine the epidemiologic characteristics
More informationOverview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing
Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,
More informationSpread of Strain W, a Highly Drug-Resistant Strain of Mycobacterium tuberculosis, Across the United States
85 Spread of Strain W, a Highly Drug-Resistant Strain of Mycobacterium tuberculosis, Across the United States Tracy B. Agerton, Sarah E. Valway, Richard J. Blinkhorn, Kenneth L. Shilkret, Randall Reves,
More informationDANISH GUIDELINES FOR PREVENTION AND TREATMENT OF TB IN CHILDREN
DANISH GUIDELINES FOR PREVENTION AND TREATMENT OF TB IN CHILDREN Troels Lillebæk Director, Consultant, DMSc, DTM&H International Reference Laboratory of Mycobacteriology / WHO TB Supranational Reference
More information(PFGE) Clostridium di$cile
2009 205 (PFGE) Clostridium di$cile 1) 3) 2) 2) 2) 2, 4) 5) 1) 2) 3) 4) 5) 21 5 22 21 8 31 2004 1 2008 12 5 Clostridium di$cile (C. di$cile) 340 248 A /B 141 (56.9) A /B 26 (10.5) A /B 81 (32.7) 136 (PFGE)
More informationGlobal epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos
Global epidemiology of drug-resistant tuberculosis Factors contributing to the epidemic of MDR/XDR-TB CHIANG Chen-Yuan MD, MPH, DrPhilos By the end of this presentation, participants would be able to describe
More information2016 Annual Tuberculosis Report For Fresno County
206 Annual Tuberculosis Report For Fresno County Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis
More informationSURVEILLANCE TECHNICAL
CHAPTER 5 SURVEILLANCE TECHNICAL ASPECTS 55 Protect - detect - protect Polio eradication strategies can be summed up as protect and detect protect children against polio by vaccinating them, and detect
More informationCOHORT STUDY OF HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS in PENANG HOSPITAL: COMPARISON OF CLINICAL MANIFESTATIONS
COHORT STUDY OF HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS in PENANG HOSPITAL: COMPARISON OF CLINICAL MANIFESTATIONS Ong CK 1, Tan WC 2, Leong KN 2, Abdul Razak M 1, Chow TS 2 1 Respiratory Unit, Penang
More informationRapid detection of mutations in rpob gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay
Indian J Med Res 117, February 2003, pp 76-80 Rapid detection of mutations in rpob gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay Meera Sharma, Sunil Sethi, Baijayantimala
More informationCommunicable Disease Control Manual Chapter 4: Tuberculosis
Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from
More informationin South Africa. Authors Coetzee, D; Hilderbrand, K; Goemaere, E; Matthys, F; Boelaert, M /j x
MSF Field Research Integrating tuberculosis and HIV care in the primary care setting in South Africa. Authors Coetzee, D; Hilderbrand, K; Goemaere, E; Matthys, F; Boelaert, M Citation DOI Journal Rights
More informationLack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial
AJRCCM Articles in Press. Published on May 18, 2006 as doi:10.1164/rccm.200511-1834oc Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial 1 Awal Khan Ph.D., 1 Timothy R. Sterling
More informationTuberculosis and HIV: Renewed Challenge
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 93(3): 417-421, May/Jun. 1998 417 RESEARCH NOTE Tuberculosis and HIV: Renewed Challenge Afranio L Kritski +, José Roberto Lapa e Silva, Marcus B Conde Unidade
More informationSputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
Journal of Antimicrobial Chemotherapy (27) 59, 794 798 doi:.93/jac/dkm25 Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? Jesús
More informationSpread of Drug-Resistant Pulmonary Tuberculosis in Estonia
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2001, p. 3339 3345 Vol. 39, No. 9 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.9.3339 3345.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationMulti-drug Resistant Tuberculosis in Rajshahi District
TAJ December 2005; Volume 18 Number 2 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Original Article Multi-drug Resistant Tuberculosis in Rajshahi District M Wasim Hussain, 1 M Azizul
More informationMedical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia
Medical Bacteriology- Lecture 10 Mycobacterium Actinomycetes Nocardia 1 Mycobacterium Characteristics - Large, very weakly gram positive rods - Obligate aerobes, related to Actinomycetes - Catalase positive
More informationThe Molecular Epidemiology of Tuberculosis
The Molecular Epidemiology of Tuberculosis Barry N. Kreiswirth,, PhD Director, PHRI TB Center Airborne pathogen, Mycobacterium tuberculosis Slow grower; doubles 24hrs; 3-4 weeks to culture 3-4 weeks for
More informationAnnual surveillance report 2015
Annual surveillance report 215 Acknowledgements The Public Health Agency Northern Ireland gratefully acknowledges all those who contributed to this report, including; physicians, nurses, microbiologists,
More informationApplication of New Diagnostics and Preventative Treatment in Low and High Burden Settings
Application of New Diagnostics and Preventative Treatment in Low and High Burden Settings Edward Nardell, MD Brigham & Women s Hospital Harvard Medical School Partners In Health Disclosures opps! Served
More informationChapter 1 Overview of Tuberculosis Epidemiology in the United States
Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United
More informationDescriptive Profile of Tuberculin Skin Testing Programs and Laboratory-Acquired Tuberculosis Infections in Public Health Laboratories
JOURNAL OF CLINICAL MICROBIOLOGY, July 1997, p. 1847 1851 Vol. 35, No. 7 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Descriptive Profile of Tuberculin Skin Testing Programs
More informationEpidemiology of Tuberculosis in Hamburg, Germany: Long-Term Population-Based Analysis Applying Classical and Molecular Epidemiological Techniques
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2002, p. 532 539 Vol. 40, No. 2 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.2.532 539.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved. Epidemiology
More informationTuberculosis in the UK. Annual report on tuberculosis surveillance in the UK 2008
Tuberculosis in the UK Annual report on tuberculosis surveillance in the UK 2008 Acknowledgements This report was prepared by the Tuberculosis Section, Health Protection Agency Centre for Infections. This
More informationFundamentals of Tuberculosis (TB)
TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported
More informationMolecular Epidemiology Study of Exogenous Reinfection in an Area with a Low Incidence of Tuberculosis
JOURNAL OF CLINICAL MICROBIOLOGY, June 2001, p. 2213 2218 Vol. 39, No. 6 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.6.2213 2218.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationInt.J.Curr.Microbiol.App.Sci (2015) 4(9):
ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 744-748 http://www.ijcmas.com Original Research Article Prevalence of HIV-TB Co-Infection and Study of its Epidemiological Variant among Patient s Attending
More informationEpidemiology of TB: A Local and National Overview
Epidemiology of TB: A Local and National Overview Sonal S. Munsiff, MD Director, Bureau of Tuberculosis Control NYC Department of Health and Mental Hygiene Medical Officer, DTBE, CDC February 4, 24 Tuberculosis
More informationMolecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Title Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium. Author(s) Ho, PL; Yam, WC; Leung, CC; Yew, WW; Mok, TYW; Chan, KS; Tam, CM Citation Hong Kong Medical
More informationTUBERCULOSIS. Famous victims in their intellectual prime: Chopin, Paganini, Thoreau, Keats, Elizabeth Browning, Brontës
TUBERCULOSIS GENERAL Tuberculosis (TB) kills 1,700,000 annually worldwide. "The Captain of all the men of death that came to take him away was the consumption, for it was that which brought him down to
More informationMonica Manandhar. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume V, A. Study Purpose and Rationale
Randomized Trial of lsoniazid as Secondary Prophylaxis for Prevention of Recurrent Pulmonary Tuberculosis in HIV-positive Patients After One Episode of Tuberculosis Monica Manandhar A. Study Purpose and
More informationORIGINAL INVESTIGATION. Reinfection Plays a Role in a Population Whose Clinical/Epidemiological Characteristics Do Not Favor Reinfection
Tuberculosis Recurrences ORIGINAL INVESTIGATION Reinfection Plays a Role in a Population Whose Clinical/Epidemiological Characteristics Do Not Favor Reinfection Darío García de Viedma, PhD; Mercedes Marín,
More informationTuberculosis transmission in the Netherlands : the role of immigration and travel Kik, S.V.
UvA-DARE (Digital Academic Repository) Tuberculosis transmission in the Netherlands : the role of immigration and travel Kik, S.V. Link to publication Citation for published version (APA): Kik, S. V. (2009).
More informationA ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia ( )
A ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011) Naira Dekhil 1, Besma Mhenni 1, Raja Haltiti 2, and Helmi Mardassi 1 (speaker)
More informationOver the past 10 years, molecular tools have become available
Determinants of cluster distribution in the molecular epidemiology of tuberculosis Megan Murray* Department of Epidemiology, Harvard School of Public Health and Infectious Disease Unit, Massachusetts General
More informationArizona Annual Tuberculosis Surveillance Report
Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case
More informationOUTBREAKS of tuberculosis often occur under
222 THE NEW ENGLAND JOURNAL OF MEDICINE July 27, 1995 OUTBREAK OF TUBERCULOSIS AMONG REGULAR PATRONS OF A NEIGHBORHOOD BAR SUSAN E. KLINE, M.D., LINDA L. HEDEMARK, M.D., AND SCOTT F. DAVIES, M.D. Abstract
More informationComplication of Bacillus Calmette-Guerin (BCG) Vaccine in HIV-infected Children
Original Article Complication of Bacillus Calmette-Guerin (BCG) Vaccine in HIV-infected Children Virat Sirisanthana, M.D.* Abstract Nine of 355 cases of symtopmatic HIV-infected children who admitted to
More informationLaboratory Reporting of Tuberculosis Test Results and Patient Treatment Initiation in California
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2004, p. 4209 4213 Vol. 42, No. 9 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.9.4209 4213.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More information